Celgene hopes device + drug can tackle aggressive brain tumours
Novocure’s Optune will be tested alongside investigational Celgene drug marizomib.
Novocure’s Optune will be tested alongside investigational Celgene drug marizomib.
Is digital the true solution to brain disorders?
Median overall survival improved from 15 months to 21 months when combined with chemotherapy.
Novocure’s Optune device shown to be safe and tolerable in recurrent ovarian cancer.